Braidwell LP Immunocore Holdings PLC Transaction History

Braidwell LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$33.78 - $63.75 $26.9 Million - $50.8 Million	797,268 New	797,268 $27 Billion
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $12.7 Million - $20.5 Million	-295,608 Reduced 32.59%	611,365 $41.8 Billion
Q3 2023 Nov 14, 2023	BUY	$49.5 - $66.6 $21.7 Million - $29.2 Million	438,946 Added 93.79%	906,973 $47.1 Billion
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $2.03 Million - $2.58 Million	41,917 Added 9.84%	468,027 $28.1 Billion
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $19.7 Million - $28 Million	426,110 New	426,110 $21.1 Billion

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.